Spirogen
Latest round
- Series B
Last raised
- May 2003
Total raised
- $12M
Investors
- 5
About Spirogen
Founded in 2000 and headquartered in London, UK, Spirogen specializes in developing advanced therapeutic solutions. The company was acquired by MedImmune, Inc. in October 2013 for USD 200 mn, with potential additional payments of up to USD 240 mn based on developmental milestones.Spirogen is involved in the research and development of innovative biopharmaceutical products, particularly in the area of oncology. The company focuses on creating antibody-drug conjugates that target and deliver treatments directly to cancer cells, thus enhancing treatment efficacy while minimizing side effects.Looking ahead, Spirogen plans to leverage the resources from its acquisition by MedImmune, Inc. to support the clinical development of its antibody-drug conjugates. The strategy includes expanding its product pipeline and launching new therapies aimed at oncology treatments.
Who invested in Spirogen
5 investors across 3 rounds
See all investors in Spirogen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Spirogen
Who invested in Spirogen?
Spirogen has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Spirogen raised?
Spirogen has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Spirogen last raise money?
Spirogen's most recent round on record is a Series B, in May 2003.
What does Spirogen do?
Founded in 2000 and headquartered in London, UK, Spirogen specializes in developing advanced therapeutic solutions.
Where is Spirogen headquartered?
Spirogen is headquartered in London, UK.
Which VCs invest in companies like Spirogen?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Spirogen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Spirogen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.